Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study to Characterize and Evaluate Markers of Chemoresistance in Patients With Metastatic Colorectal Cancer

NCT00559676 is registered in ClinicalTrials.gov with Centre Hospital Regional Universitaire de Limoges as lead sponsor.

NCT NCT00559676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study to Characterize and Evaluate Markers of Chemoresistance in Patients With Metastatic Colorectal Cancer
Lead sponsor
Centre Hospital Regional Universitaire de Limoges
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2005
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer